We rely on peer-reviewed studies, academic research institutions, and medical associations
Clinical Trial Safety Data: Across multiple studies using oral and intravenous AOD-9604 for up to 24 weeks, the peptide demonstrated an excellent safety profile indistinguishable from placebo
The body requires B12 to produce healthy cells at a rate that supports wound healing
Patients should be informed in advance of the temporary loss of sensation and motor activity that they may experience after administration of this medication
The funder designed the trial, oversaw its conduct, monitored trial sites, and collected and analyzed the data
Possible Benefits in Multiple Sclerosis Preliminary research suggests methylcobalamin could be beneficial in treating multiple sclerosis (MS), a degenerative autoimmune disease